Rapid, flow cytometric assay for NK alloreactivity reveals exceptions to rules governing alloreactivity.

[1]  Thi H. O. Nguyen,et al.  Killer Ig-Like Receptor Ligand Mismatch Directs NK Cell Expansion In Vitro , 2009, The Journal of Immunology.

[2]  M. Martinetti,et al.  Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. , 2009, Blood.

[3]  H. Ljunggren,et al.  Estimation of the Size of the Alloreactive NK Cell Repertoire: Studies in Individuals Homozygous for the Group A KIR Haplotype1 , 2008, The Journal of Immunology.

[4]  Peter Parham,et al.  MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. , 2008, Blood.

[5]  L. Ruggeri,et al.  Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1. , 2008, Blood.

[6]  F. Christiansen,et al.  The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations. , 2008, Blood.

[7]  F. Christiansen,et al.  KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals. , 2008, International immunology.

[8]  P. Parham,et al.  Synergistic Polymorphism at Two Positions Distal to the Ligand-Binding Site Makes KIR2DL2 a Stronger Receptor for HLA-C Than KIR2DL31 , 2008, The Journal of Immunology.

[9]  J. Chewning,et al.  KIR2DS1-Positive NK Cells Mediate Alloresponse against the C2 HLA-KIR Ligand Group In Vitro1 , 2007, The Journal of Immunology.

[10]  P. Parham,et al.  Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function , 2006, The Journal of experimental medicine.

[11]  L. Lybarger,et al.  Licensing of natural killer cells by host major histocompatibility complex class I molecules , 2005, Nature.

[12]  M. Martelli,et al.  Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer. , 2005, Current opinion in immunology.

[13]  Jessica M Malenfant,et al.  CD107a as a functional marker for the identification of natural killer cell activity. , 2004, Journal of immunological methods.

[14]  S. Forman,et al.  Development of a multiplex PCR-SSP method for Killer-cell immunoglobulin-like receptor genotyping. , 2004, Tissue antigens.

[15]  Daniel J Weisdorf,et al.  Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor. , 2002, Blood.

[16]  Katia Perruccio,et al.  Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants , 2002, Science.

[17]  R. Vance,et al.  Regulation of the natural killer cell receptor repertoire. , 2001, Annual review of immunology.

[18]  Eric O Long,et al.  Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. , 1998, Journal of immunology.

[19]  O. Mandelboim,et al.  Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules , 1996, The Journal of experimental medicine.

[20]  P. Parham,et al.  The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor , 1995, The Journal of experimental medicine.

[21]  E. Brooks,et al.  Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. , 1993, Science.

[22]  H. Sakai.  Lymphocyte Function in IgA Nephropathy , 1987 .